Newsroom | 1555 results
Sorted by: Latest
-
New Data Show Delve Bio’s Metagenomic Platform Accurately Identifies Viruses and Their Subtypes With a Single Test
BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data showing that its groundbreaking infectious disease test, Delve Detect, is also capable of viral subtyping for select pathogens from sequence data analyzed through its proprietary bioinformatics pipeline, Delve Decide. The data will be presented at the Pan American Society for Clinical Virology (PASCV) Annual Meeting on May 8, 2025, in Clearwater, Florida....
-
Empath Health Introduces One Hospice Model, Bringing Together Florida’s Established Not-for-Profit Hospices Under One Mission
CLEARWATER, Fla.--(BUSINESS WIRE)--Empath Health, one of the nation’s largest 501(c)(3) integrated care networks, today unveiled its One Hospice Model—a first-of-its-kind framework that preserves community-based hospice while adding the scale, innovation and accountability of a statewide system. “Families deserve hospice that puts mission before margin,” said Jonathan D. Fleece, President & CEO of Empath Health. “By uniting Florida’s most trusted not-for-profit hospices under one model, we...
-
Turn Therapeutics Announces Vaccine Breakthrough: Validates 100% VSV Recovery from Petrolatum Carrier at 24 and 72 Hours
LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced today that it has achieved a critical milestone in its effort to reduce dependency on cold-storage for vaccines. In partnership with the nonprofit International AIDS Vaccine Initiative, Turn Therapeutics has validated a standardized assay and demonstrated 100% recovery of vesicular stomatitis virus (VSV) -- a widely used viral backbone in vaccine development -- after both 24 an...
-
Gilead Sciences Announces First Quarter 2025 Financial Results
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its first quarter 2025 results of operations. “Gilead had a strong start to the year driven by excellent commercial and clinical execution along with disciplined expense management,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “Our base business grew 4% year-over-year, primarily led by Biktarvy’s continued strength, and we announced positive topline Phase 3 results for Trodelvy plus...
-
The Pandemic Agreement Finalized, but Falls Short, says AHF
MEXICO CITY & MIAMI & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute acknowledge the conclusion of three years of negotiations on the global pandemic agreement text by congratulating the negotiators—particularly representatives of the Equity and Africa Groups—and recognizing the contributions of key stakeholders, including civil society, who championed equitable access to public health goods. “Even before the COVID-19 pandemic, we beg...
-
Soleo Health Selected as Exclusive In-Network Specialty Pharmacy for Qfitlia™ a Treatment Option for Adults With Hemophilia A and B With and Without Inhibitors
FRISCO, Texas--(BUSINESS WIRE)--SOLEO HEALTH SELECTED AS EXCLUSIVE IN-NETWORK SPECIALTY PHARMACY FOR QFITLIA™ TREATMENT OPTION FOR ADULTS WITH HEMOPHILIA A&B WITH/WITHOUT INHIBITORS...
-
Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the BofA Securities 2025 Healthcare Conference on Tuesday, May 13th, 2025. Management will participate in a Fireside Chat at 1:40 p.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available approx...
-
AHF desmiente información falsa sobre el SIDA y la transmisión del VIH por alimentos
Ciudad de México--(BUSINESS WIRE)--En los últimos días, comenzó a circular en redes sociales y plataformas de mensajería instantánea una cadena que asegura que un niño de 10 años contrajo VIH en Barbados tras comer piña contaminada con sangre. A raíz de este mensaje, que se ha viralizado en varios países de América Latina y el Caribe, AHF América y El Caribe considera necesario aclarar públicamente que esta información es falsa y carece por completo de base científica. Desde AIDS Healthcare Fou...
-
AHF Refutes Misinformation About AIDS and Food Transmission
MEXICO CITY--(BUSINESS WIRE)--In recent days, a message has been circulating on social media and messaging platforms claiming that a 10-year-old boy in Barbados contracted HIV after eating pineapple contaminated with blood. In response to this message, which has gone viral in several countries across Latin America and the Caribbean, AHF Latin America & Caribbean finds it necessary to publicly clarify that this information is false and entirely lacking in scientific basis. AIDS Healthcare Fo...
-
New Robert Vargas Mural Honors Fight Against Hunger
LOS ANGELES--(BUSINESS WIRE)--New Robert Vargas Mural Honors Fight Against Hunger...